Jersey City-based TrialScope, a clinical trial disclosure and transparency management technology company, announced on Wednesday a strategic partnership with Washington-D.C-based Vivli, a nonprofit focused on sharing of clinical trial data.
In a statement TrialScope said that the collaboration would offer sponsors and researchers access to the most complete solution for disclosure and data sharing.
“There is a growing trend towards increased transparency within the clinical trial industry, not just to meet regulatory requirements, but as an ethical obligation to advance science and promote patient safety,” said TrialScope CEO Jeff Kozloff in a statement.
“We are honored to work with Vivli as a partner to provide our customers with a seamless and efficient platform for all of their data-sharing needs. We appreciate the fact that Vivli is disease agnostic and can synthesize data from multiple repositories, which will greatly reduce duplication of clinical trials, putting fewer patients through studies unnecessarily,” said Kozloff.
“We are delighted to partner with TrialScope, which is recognized as the leader in clinical trial disclosure,” said Rebecca Li, executive director of Vivli.
“Together, we offer an end-to-end solution. There is simply no complete solution for researchers and sponsors alike, who want to spend less time searching for previous data, and more time on advancing science,” said Li.
TrialScope said that its SaaS-based, centralized approach has met the disclosure and transparency needs of the trial industry from large pharmaceutical companies (13 of the top 15) to smaller biotech firms for more than five years. By working with Vivli, the company can offer its customers the most comprehensive approach to disclosure and data sharing in the market.
The alliance, according to TrialScope, draws on complementary strengths of each partner and will deliver an opportunity for sponsors to address their disclosure and transparency needs including: Disclosure and data-sharing software and advisory services; technology to help people find help people find relevant, authoritative clinical trial information online; the ability to host anonymized individual participant data; and the ability for sponsors to share their data in a secure research environment.
